首页> 外文会议>Colloque me?decine et recherche >microRNAs in Sporadic Alzheimer's Disease and Related Dementias
【24h】

microRNAs in Sporadic Alzheimer's Disease and Related Dementias

机译:Micrornas在零星阿尔茨海默病和相关痴呆症

获取原文

摘要

Recent studies have demonstrated that non-coding microRNAs (miR-NAs), which function at the posttranscriptional level as a rheostat of the transcrip-tome and proteome, control a variety of neuronal functions as well as neuronal survival. Studies performed in humans support the idea that changes in miRNA expression profiles or target sequences could significantly contribute to the risk of major neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). MiRNAs seem to participate directly in the regulation of expression of AD-related genes, including APP and BACE1/beta-secretase, which are involved in the neurotoxic Abeta peptide production; the latter accumulates in the brains of AD patients. This observation is interesting, as gene dosage effects of the APP gene can cause genetic AD. In this regard, miRNA research appears to be particularly promising for the understanding of the very frequent and poorly understood sporadic forms of AD and probably other neurological disorders.
机译:最近的研究表明,非编码微大罗氏(MIR-NAS),其在后颅面水平中作为转录物 - Tome和蛋白质组的变性抑制,控制各种神经元功能以及神经元存活。人类进行的研究支持MiRNA表达谱或靶序列的变化可能会显着促进主要神经变性疾病,如Alzheimer疾病(AD)和帕金森病(PD)。 MiRNAS似乎直接参与了在涉及神经毒性Abeta肽生产的AP相关基因表达的调节中,包括应用和Bace1 /β-分泌酶;后者积累在AD患者的大脑中。这种观察是有趣的,因为APP基因的基因剂量效应会导致遗传广告。在这方面,MiRNA研究似乎特别有希望,了解对散发的散发形式的广告和可能其他神经系统疾病的理解特别有希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号